(Q38027567)

English

A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs

scientific article published on August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs (English)

1 reference

Europe PubMed Central

27 August 2017

0 references

histamine antagonist

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Ryan M Carnahan

5

1 reference

Europe PubMed Central

27 August 2017

Jayna M Holroyd-Leduc

4

object named as

Jayna Holroyd-Leduc

1 reference

Europe PubMed Central

27 August 2017

Cara Tannenbaum

1

object named as

Cara Tannenbaum

1 reference

Europe PubMed Central

27 August 2017

3

object named as

Sarah Hilmer

1 reference

Europe PubMed Central

27 August 2017

author name string

Amélie Paquette

2

1 reference

Europe PubMed Central

27 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2012

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

29

1 reference

Europe PubMed Central

27 August 2017

8

1 reference

Europe PubMed Central

27 August 2017

639-658

1 reference

Europe PubMed Central

27 August 2017

https://scigraph.springernature.com/pub.10.2165/11633250-000000000-00000

0 references

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Incidence and preventability of adverse drug events among older persons in the ambulatory setting

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Mild cognitive impairment: ten years later

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

V. A. Kral and the origins of benign senescent forgetfulness and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Evidence that age-associated memory impairment is not a normal variant of aging.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Incidence of mild cognitive impairment: a systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Mild cognitive impairment, amnestic type: an epidemiologic study.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Risk profiles for mild cognitive impairment and progression to dementia are gender specific.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Anxiety and cognitive performance: attentional control theory

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Stress hormones and human memory function across the lifespan

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cholinergic modulation of the cortical neuronal network

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Histamine in the brain: beyond sleep and memory

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cognitive Effects of Long-Term Benzodiazepine Use

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Comparative cognitive and subjective side effects of immediate-release oxycodone in healthy middle-aged and older adults.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

What is "quality of evidence" and why is it important to clinicians?

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Triazolam and zolpidem: effects on human memory and attentional processes.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Sensitivity to triazolam in the elderly.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Sedative, memory, and performance effects of hypnotics.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

An examination of differences in the time course of oxazepam's effects on implicit vs explicit memory.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

A further examination of the time-dependent effects of oxazepam and lorazepam on implicit and explicit memory.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of oxazepam and lorazepam on implicit and explicit memory: evidence for possible influences of time course.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Sedation and memory: studies with a histamine H-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected].

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Amnestic and anxiolytic effects of alprazolam in oral surgery patients.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cognition and Vigilance: Differential Effects of Diazepam and Buspirone on Memory and Psychomotor Performance

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and time

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Memory performance in individuals with primary degenerative dementia: its similarity to diazepam-induced impairments.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effect of a single dose of diazepam on balance measures in older people

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Assessment of cognitive function of the elderly population: effects of darifenacin

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjects

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Short-term effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA).

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Benzodiazepine use and cognitive function among community-dwelling elderly.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Consumption of psychotropic medication in the elderly: a re‐evaluation of its effect on cognitive performance

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Use of medications with anticholinergic properties and cognitive function in a young-old community sample

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Tricyclic antidepressants and cognitive decline.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Long-term cognitive impact of anticholinergic medications in older adults.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Use of anticholinergics and the risk of cognitive impairment in an African American population

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Tranquillising memories: a review of the effects of benzodiazepines on human memory

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.2165%2F11633250-000000000-00000

21 January 2018

Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of chlorpromazine and benzhexol on memory and psychomotor function in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Drug Burden Index to Define the Functional Burden of Medications in Older People

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on performance and sleepiness with the H1-antihistamine, desloratadine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clorazepate, diazepam, lorazepam, and placebo on human memory

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mild cognitive impairment: long-term course of four clinical subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anterograde amnesia with oral lorazepam.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparison of the pharmacodynamic effects of single doses of lofepramine, amitriptyline and placebo in elderly subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential Adverse Outcomes of Psychotropic and Narcotic Drug Use in Canadian Seniors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22812538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11633250-000000000-00000

1 reference

Europe PubMed Central

27 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38027567&oldid=1750156332"